SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

LORENZETTI, Stefano et al. Innovative non-animal testing strategies for reproductive toxicology: the contribution of Italian partners within the EU project ReProTect. Ann. Ist. Super. Sanità [online]. 2011, vol.47, n.4, pp. 429-444. ISSN 0021-2571.  http://dx.doi.org/10.4415/ANN_11_04_16.

    1. Mantovani A. Risk assessment of endocrine disrupters: the role of toxicological studies. Ann N Y Acad Sci 2006;1076:239-52. [ Links ]

    2. Frazzoli C, Petrini C, Mantovani A. Sustainable development and next generation's health: a long-term perspective about the consequences of today's activities for food safety. Ann Ist Super Sanità 2009;45:65-75. [ Links ]

    3. Williams ES, Panko J, Paustenbach DJ. The European Union's REACH regulation: a review of its history and requirements. Crit Rev Toxicol 2009;39:553-75. [ Links ]

    4. Spielmann H. The way forward in reproductive/developmental toxicity testing. Altern Lab Anim 2009;37:641-56. [ Links ]

    5. Ahlers J, Stock F, Werschkun B. Integrated testing and intelligent assessment-new challenges under REACH. Environ Sci Pollut Res Int 2008;15:565-72. [ Links ]

    6. European Food Safety Authority. Existing approaches incorporating replacement, reduction and refinement of animal testing: applicability in food and feed risk assessment. The EFSA Journal 2009;1052:37-77. [ Links ]

    7. Griesinger C, Hayes W, Guzelian P. Proceedings of the 1st International Forum towards evidence-based toxicology (EBT). Hum Exp Toxicol 2009;28(2-3):71-165. [ Links ]

    9. Hartung T. From alternative methods to a new toxicology. Eur J Pharm Biopharm 2011;77(3):338-49. [ Links ]

    10. Hareng L, Pellizzer C, Bremer S, Schwarz M, Hartung T. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. Reprod Toxicol 2005;20:441-52. [ Links ]

    11. Hartung T, Bremer S, Casati S, Coecke S, Corvi R, Fortaner S, Gribaldo L, Halder M, Hoffmann S, Roi AJ, Prieto P, Sabbioni E, Scott L, Worth A, Zuang V. A modular approach to the ECVAM principles on test validity. Altern Lab Anim 2004;32:467-72. [ Links ]

    12. Luciano AM, Franciosi F, Lodde V, Corbani D, Lazzari G, Crotti G, Galli C, Pellizzer C, Bremer S, Weimer M, Modina SC. Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte maturation (IVM) test within ReProTect. Reprod Toxicol 2010;30:81-8. [ Links ]

    13. Bremer S, Cortvrindt R, Daston G, Eletti B, Mantovani A, Maranghi F, Pelkonen O, Ruhdel I, Spielmann H. Reproductive and Developmental Toxicity. ATLA 2005;33(Suppl.1):183-209. [ Links ]

    14. Lorenzetti S, Marcoccia D, Narciso L, Mantovani A. Cell viability and PSA secretion assays in LNCaP cells: a tiered in vitro approach to screen chemicals with a prostate-mediated effect on male reproduction within the ReProTect project. Reprod Toxicol 2010;30:25-35. [ Links ]

    15. Freyberger A, Wilson V, Weimer M, Tan S, Tran HS, Ahr HJ. Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor-alpha binding assay: protocol optimization and intralaboratory assay performance as initial steps towards validation. Reprod Toxicol 2010;30:50-9. [ Links ]

    16. Freyberger A, Witters H, Weimer M, Lofink W, Berckmans P, Ahr HJ. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation. Reprod Toxicol 2010;30:9-17. [ Links ]

    17. Hewitt M, Ellison CM, Enoch SJ, Madden JC, Cronin MT. Integrating (Q)SAR models, expert systems and read-across approaches for the prediction of developmental toxicity. Reprod Toxicol 2010;30:147-60. [ Links ]

    18. Schenk B, Weimer M, Bremer S, van der Burg B, Cortvrindt R, Freyberger A, Lazzari G, Pellizzer C, Piersma A, Schäfer WR, Seiler A, Witters H, Schwarz M. The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. Reprod Toxicol 2010;30:200-18. [ Links ]

    19. Anonymous. Alternative testing strategies. Progress Report 2009. Replacing, reducing and refining use of animals in research. (Genomics and Biotechnolgy for Health -EUR 23886). Luxembourg: Office for Official Publications of the European Communities; 2009. p. 1-280. [ Links ]

    20. Bremer S, Balduzzi D, Cortvrindt R, Daston G, Eletti B, Galli A, Huhtaniemi I, Laws S, Lazzari G, Liminga U, Smitz J, Spano M, Themmen A, Tilloy A, Waalkens Behrends I. The effects of chemicals on mammalian fertility. The report and recommendations of ECVAM Workshop 53-the first strategic workshop of the EU ReProTect Project. Altern Lab Anim 2005;33:391-416. [ Links ]

    21. Larsen L, Scheike T, Jensen TK, Bonde JP, Ernst E, Hjollund NH Zhou Y, Skakkebaek NE, Giwercman A. Computer-assisted semen analysis parameters as predictors for fertility of men from the general population. The Danish First Pregnancy Planner Study Team. Human Reproduction 2000;15:1562-7. [ Links ]

    22. Spanò M, Bonde JP, Hjøllund HI, Kolstad HA, Cordelli E, Leter G. Sperm chromatin damage impairs human fertility. The Danish First Pregnancy Planner Study Team. Human Reproduction 2000;73:43-50. [ Links ]

    23. Tegelenbosch-Schouten MM, Arabi S, Balduzzi D, van Bilsen JHM, Brouwer MLHMH, Dijkstra A, Galli A, van der Horst-Groeneveld LJML, Theunissen PT, Wolterbeek APM,Waalkens-Berendsen ID. Bovine spermatozoa: an in vitro model for reproductive toxicity?. Reprod Toxicol 2006;22:285-6. [ Links ]

    24. Katz DF, Davis RO, Delandmeter BA, Overstreet JW. Real-time analysis of sperm motion using automatic video image digitization. Comput Methods Prog Biomed 1985;21:173-82. [ Links ]

    25. Balduzzi D, Signori T, Galli A. Comparison among three fluorescent staining methods to evaluate sperm viability by flow cytometry. Gametes: Development and function 1998;507. [ Links ]

    26. Ritz C and Streibig JC. Bioassay Analysis using R. J Statist Software 2005;12:5. [ Links ]

    27. Aitken RJ, De Iuliis GN. On the possible origins of DNA damage in human spermatozoa. Mol Hum Reprod 2010; 16:3-13. [ Links ]

    28. Marchetti F, Wyrobek AJ. Mechanisms and consequences of paternally-transmitted chromosomal abnormalities. Birth Defects Res C Embryo Today 2005;75:112-29. [ Links ]

    29. Cordelli E, Eleuteri P, Leter G, Rescia M, and Spano M. Flow cytometry applications in the evaluation of sperm quality: semen analysis, sperm function and DNA integrity. Contraception 2005;72:273-9. [ Links ]

    30. Speit G, Vasquez M, Hartmann A. The comet assay as an indicator test for germ cell genotoxicity. Mutat Res 2009;681:3-12. [ Links ]

    31. Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 2004;26:249-61. [ Links ]

    32. Cordelli E, Fresegna AM, D'Alessio A, Eleuteri P, Spano M, Pacchierotti F, Villani P. ReProComet: a new in vitro method to assess DNA damage in mammalian sperm. Toxicol Sci 2007;99:545-52. [ Links ]

    33. Villani P, Spanò M, Pacchierotti F, Weimer M, Cordelli E. Evaluation of a modified comet assay to detect DNA damage in mammalian sperm exposed in vitro to different mutagenic compounds. Reprod Toxicol 2010;30:44-9. [ Links ]

    34. Gedik CM, Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J 2005;19:82-4. [ Links ]

    35. Langie SA, Knaapen AM, Brauers KJ, van Berl D, van Schooten FJ, Godschalk RW. Development and validation of a modified comet assay to phenotypically assess nucleotide excision repair. Mutagenesis 2006;21:153-8. [ Links ]

    36. Anderson D, Basaran N, Dobrzyn'ska MM, Basaran AA, Yu TW. Modulating effects of flavonoids on food mutagens in human blood and sperm samples in the comet assay. Teratog Carcinog Mutagen 1997;17:45-58. [ Links ]

    37. Anderson D, Dobrzyn'ska MM, Basaran N. Effect of various genotoxins and reproductive toxins in human lymphocytes and sperm in the Comet assay. Teratog Carcinog Mutagen 1997;17:29-43. [ Links ]

    38. Anderson D, Dobrzyn'ska MM, Yu TW, Gandini L, Cordelli E, Spano M. DNA integrity in human sperm. Teratog Carcinog Mutagen 1997;17:97-102. [ Links ]

    39. Anderson D, Dobrzyn'ska MM, Bas¸aran N, Bas¸aran A, Yu TW. Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm. Mutat Res 1998;402:269-77. [ Links ]

    40. Anderson D, Schmid TE, Baumgartner A, Cemeli-Carratala E, Brinkworth MH, Wood JM. Oestrogenic compounds and oxidative stress (in human sperm and lymphocytes in the Comet assay). Mutat Res 2003;544:173-8. [ Links ]

    41. Arabi M. Bull spermatozoa under mercury stress. Reprod Dom Anim 2005;40:454-9. [ Links ]

    42. Bennetts LE, Aitken RJ. A comparative study of oxidative DNA damage in mammalian spermatozoa. Mol Reprod Dev 2005;71:77-87. [ Links ]

    43. Bennetts LE, De Iuliis GN, Nixon B, Kime M, Zelski K, McVicar CM, Lewis SE, Aitken RJ. Impact of estrogenic compounds on DNA integrity in human spermatozoa: evidence for cross-linking and redox cycling activities. Mutat Res 2008;641:1-11. [ Links ]

    44. Fatehi AN, Bevers MM, Schoevers E, Roelen BA, Colenbrander B, Gadella BM. DNA damage in bovine sperm does not block fertilization and early embryonic development but induces apoptosis after the first cleavages. J Androl 2006;27:176-88. [ Links ]

    45. Gavella M, Garaj-Vrhovac V, Lipovac V, Antica M, Gajski G, Car N. Ganglioside GT1b protects human spermatozoa from hydrogen peroxide-induced DNA and membrane damage. Int J Androl 2010;33:536-44. [ Links ]

    46. Haines G, Marples B, Daniel P, Morris I. DNA damage in human and mouse spermatozoa after in vitro-irradiation assessed by the Comet assay. Adv Exp Med Biol 1998;444:79-91. [ Links ]

    47. Mansour G, Aziz N, Sharma R, Falcone T, Goldberg J, Agarwal A. The impact of peritoneal fluid from healthy women and from women with endometriosis on sperm DNA and its relationship to the sperm deformity index. Fertil Steril 2009;92:61-7. [ Links ]

    48. Salazar-Arredondo E, de Jesús Solís-Heredia M, Rojas-García E, Hernández-Ochoa I, Quintanilla-Vega B. Sperm chromatin alteration and DNA damage by methyl-parathion, chlorpyrifos and diazinon and their oxon metabolites in human spermatozoa. Reprod Toxicol 2008;25:455-60. [ Links ]

    49. Sipinen V, Laubenthal J, Baumgartner A, Cemeli E, Linschooten JO, Godschalk RW, Van Schooten FJ, Anderson D, Brunborg G. In vitro evaluation of baseline and induced DNA damage in human sperm exposed to benzo[a]pyrene or its metabolite benzo[a]pyrene-7,8-diol-9,10-epoxide, using the comet assay. Mutagenesis 2010;25:417-25. [ Links ]

    50. Villani P, Eleuteri P, Grollino MG, Rescia M, Altavista P, Spanò M, Pacchierotti F, Cordelli E. Sperm DNA fragmentation induced by DNAse I and hydrogen peroxide: an in vitro comparative study among different mammalian species. Reproduction 2010;140:445-52. [ Links ]

    51. Zini A, San Gabriel M, Libman J. Lycopene supplementation in vitro can protect human sperm deoxyribonucleic acid from oxidative damage. Fertil Steril 2010;94:1033-6. [ Links ]

    52. Lorenzetti S, Lagatta V, Marcoccia D, Aureli F, Cubadda F, Aricò E, Canini I, Castiello L, Parlato S, Gabriele L, Maranghi F, Mantovani A. Functional assays, integrated with gene expression signatures, as predictive toxicological biomarkers: from toxicogenomics to phenotypic anchoring. Toxicol Lett 2008;180S(S1):S123-4. [ Links ]

    53. Lorenzetti S, Marcoccia D, Narciso L, Mantovani A. Cell viability and PSA secretion assays in LNCaP cells: a tiered in vitro approach to screen chemicals with a prostate-mediated effect on male reproduction within the ReProTect project. Reprod Toxicol 2010;30(1):25-35. [ Links ]

    54. O'Shaughnessy PJ, Morris ID, Huhtaniemi I, Baker PJ, Abel MH. Role of androgen and gonadotrophins in the development and function of the Sertoli cells and Leydig cells: data from mutant and genetically modified mice. Mol Cell Endocrinol 2009;306(1-2):2-8. [ Links ]

    55. Jonsson M, Lundwall A, Malm J. The semenogelins: proteins with functions beyond reproduction? Cell Mol Life Sci 2006;63(24):2886-8. [ Links ]

    56. Veveris-Lowe TL, Kruger SJ, Walsh T, Gardiner RA, Clements JA. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches. Semin Thromb Hemost 2007;33(1):87-99. [ Links ]

    57. Clements JA, Willemsen NM, Myers SA, Dong Y. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 2004;41(3):265-312. [ Links ]

    58. Balk SP, Ko YJ, Bubley GJ. Biology of prostate-specific antigen. J Clin Oncol 2003;21(2):383-91. [ Links ]

    59. Pampalakis G, Sotiropoulou G. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer. Biochim Biophys Acta 2007;1776(1):22-31. [ Links ]

    60. Lundwall A, Brattsand M. Kallikrein-related peptidases. Cell Mol Life Sci 2008;65(13):2019-38. [ Links ]

    61. Kim J, Coetzee GA. Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem 2004;93(2):233-41. [ Links ]

    62. McPhaul MJ. Mechanisms of prostate cancer progression to androgen independence. Best Pract Res Clin Endocrinol Metab 2008;22(2):373-88. [ Links ]

    63. Finne P, Finne R, Auvinen A, Juusela H, Aro J, Määttänen L, Hakama M, Rannikko S, Tammela TL, Stenman U. 2000. Predicting the outcome of prostate biopsy in screenpositivemen by amultilayer perceptron network. Urology 2000;56(3):418-22. [ Links ]

    64. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43(4):1809-18. [ Links ]

    65. Fizazi K, Navone NM. Preclinical models of prostate cancer. Bull Cancer 2005;92(2):129-41. [ Links ]

    66. Wetherill YB, Fisher NL, Staubach A, Danielsen M, de Vere White RW, Knudsen KE. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status. Cancer Res 2005;65(1):54-65. [ Links ]

    67. Schulte-Hermann R, Wogan GN, Berry C, Brown NA, Czeizel A, Giavini E, Holmes LB, Kroes R, Nau H, Neubert D, Oesch F, Ott T, Pelkonen O, Robert-Gnansia E, Sullivan FM. Analysis of reproductive toxicity and classification of glufosinate-ammonium. Regul Toxicol Pharmacol 2006;44(3 Suppl.1):S1-76. [ Links ]

    68. Can A, Albertini DF. Stage specific effects of carbendazim (MBC) on meiotic cell cycle progression in mouse oocytes. Mol Reprod Dev 1997;46:351-62. [ Links ]

    69. Jung T, Fulka J Jr, Lee C, Moor RM. Effects of the protein phosphorylation inhibitor genistein on maturation of pig oocytes in vitro. J Reprod Fertil 1993;98:529-35. [ Links ]

    70. Lazzari G, Tessaro I, Crotti G, Galli C, Hoffmann S, Bremer S, Pellizzer C. Development of an in vitro test battery for assessing chemical effects on bovine germ cells under the ReProTect umbrella. Toxicol Appl Pharmacol 2008;233:360 [ Links ]

    71. Lu Z, Xia G, Byskov AG, Andersen CY. Effects of amphotericin B and ketoconazole on mouse oocyte maturation: implications on the role of meiosis-activating sterol. Mol Cell Endocrinol 2000;164:191-6. [ Links ]

    72. Maro B, Johnson MH, Webb M, Flach G. Mechanism of polar body formation in the mouse oocyte: an interaction between the chromosomes, the cytoskeleton and the plasma membrane. J Embryol Exp Morphol 1986;92:11-32. [ Links ]

    73. Moor RM, Crosby IM. Protein requirements for germinal vesicle breakdown in ovine oocytes. J Embryol Exp Morphol 1986;94:207-20. [ Links ]

    74. Sirard MA, Florman HM, Leibfried-Rutledge ML, Barnes FL, Sims ML, First NL. Timing of nuclear progression and protein synthesis necessary for meiotic maturation of bovine oocytes. Biol Reprod 1989;40:1257-63. [ Links ]

    75. Yamashita Y, Shimada M, Okazaki T, Maeda T, Terada T. Production of progesterone from de novo-synthesized cholesterol in cumulus cells and its physiological role during meiotic resumption of porcine oocytes. Biol Reprod 2003;68:1193-8. [ Links ]

    76. Watanabe T, Shimada T, Endo A. Mutagenic effects of cadmium on mammalian oocyte chromosomes. Mutat Res 1979;67:349-56. [ Links ]

    77. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 1991;92:167-73. [ Links ]

    78. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 2000;54:138-53. [ Links ]

    79. Kwack SJ, Kwon O, Kim HS, Kim SS, Kim SH, Sohn KH, Lee RD, Park CH, Jeung EB, An BS, Park KL. Comparative evaluation of alkylphenolic compounds on estrogenic activity in vitro and in vivo. J Toxicol Environ Health A 2002;65:419-31. [ Links ]

    80. Hong EJ, Choi KC, Jeung EB. Maternal-fetal transfer of endocrine disruptors in the induction of Calbindin- D9K mRNA and protein during pregnancy in rat model. Mol Cell Endocrinol 2003;212:63-72. [ Links ]

    81. Bechi N, Ietta F, Romagnoli R, Focardi S, Corsi I, Buffi C, et al. Estrogen-like response to p-nonylphenol in human first trimester placenta and BeWo choriocarcinoma cells. Toxicol Sci 2006;93:75-81. [ Links ]

    82. Rama S, Petrusz P, Rao AJ. Hormonal regulation of human trophoblast differentiation: a possible role for 17beta-estradiol and GnRH. Mol Cell Endocrinol 2004;218:79-94. [ Links ]

    83. Miller RK, Genbacev O, Turner MA, Aplin JD, Caniggia I, Huppertz B. Human placental explants in culture: approaches and assessments. Placenta 2005;26:439-48. [ Links ]

    84. Caniggia I, Taylor CV, Ritchie JW, Lye SJ, Letarte M. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 1997;138:4977-88. [ Links ]

    85. Chaouat G, Dubanchet S, Ledée N. Cytokines: important for implantation? J Assist Reprod Genet 2007;24:491-505. [ Links ]

    86. Robertson SA, Mau VJ, Hudson SN, Tremellen KP. Cytokineleukocyte networks and the establishment of pregnancy. Am J Reprod Immunol 1997;37:438-42. [ Links ]

    87. Saito S. Cytokine cross-talk between mother and the embryo/placenta. J Reprod Immunol 2001;52:15-33. [ Links ]

    88. Bechi N, Ietta F, Romagnoli R, Jantra S, Cencini M, Galassi G, Serchi T, Corsi I, Focardi S, Paulesu L. Environmental levels of para-nonylphenol are able to affect cytokine secretion in human placenta. Environ Health Perspect 2010;118:427-31. [ Links ]

    89. Bonefeld-Jørgensen EC, Long M, Hofmeister MV, Vinggaard AM. Endocrine disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data. Environ Health Perspect 2007;115:69-76. [ Links ]

    90. Kawaguchi M, Inoue K, Sakui N, Ito R, Izumi S, Makino T, Okanouchi N, Nakazawa H. Stir bar sorptive extraction and thermal desorption-gas chromatography-mass spectrometry for the measurement of 4-nonylphenol and 4-tert-octylphenol in human biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 2004;799:119-25. [ Links ]

    91. Tan BLL, Nohd MA. Analysis of selected pesticides and alkylphenols in human cord blood by gas chromatographymass spectrometer. Talanta 2003;61:385-91. [ Links ]

    92. Mørck TJ, Sorda G, Bechi N, Rasmussen BS, Nielsen JB, Ietta F, Rytting E, Mathiesen L, Paulesu L, Knudsen LE. Placental transport and in vitro effects of Bisphenol A. Reprod Toxicol 2010;30(1):131-7. [ Links ]

    93. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:EN:PDF. [ Links ]